MOFPIGovernment of India

ORGANIZERS SPONSOR

P R O C E E D I N G S

ContentsIntroduction 04 – 05

Participant Profile 06 – 08

Program Itinerary 09

Ceremonies 10 – 11

Awards 12 – 14

Conference & Panel Discussions 15 – 36

International Tradeshow 37

Business Partnering 38

Gallery 39

Media Coverage 40

Potential NEXTThe vision for a progressive economy and a better life for mankind at large are incomplete without an understanding of the sources of sustenance of life itself - food. In this context, while the Green Revolution heralded in evolutionary changes in Agriculture, the battle to ensure global food security still continues. The reasons are not far to find: growing population, deteriorating production environments compounded by the growing menace of global warming, supply chain constraints, and a general neglect of the potential of agriculture have led to a steep decline in global food stocks and the sky-rocketing of food commodity prices.

At the same time, it would be incorrect to say, nothing has done to redress the situation. There are various instances of in depth focus on better crop management and the leveraging of biotechnology for the benefit of Agriculture is already a growing phenomenon. What is missing is bringing all these movements together to take stock of the big picture and to formulate the vision for the step ahead.

AgBioAsia

2013

• 04 •

• •05

Welcome to AgBioAsia 2013A unique platform created solely to bring together the powers of biotechnology and commerce to leverage agriculture and move towards a sustainable level of global food security. In other words, AgBioAsia 2013 will converge on one linear length the depth of path-breaking perspectives, innovative technological interventions and the strength of commercial support all in order to empower agriculture to meet its global obligations.

The first agri-summit of its kind, AgBioAsia 2013 has been conceptualized and is promoted by the Government of Andhra Pradesh in partnership with reputed international organisations, including ICRISAT and FABA. It will be held in conjunction with BioAsia 2013 - the benchmarked global forum for Biotechnology - and will align itself to the overarching theme of TECHNOLOGIES. BUSINESS. NEXT.

While the larger interest of this forum will always be a sustainable agro-future for the global population, AgBioAsia 2013 will particularly facilitate key thought leaders in agri-biotechnology to discuss, debate and conclude possibilities in:sky-rocketing of food commodity prices.

1. Crop Biotechnology

2. Food Biotechnology and Food Processing

3. Nutraceutical

Focus NOW

This genre of biotechnology has been silently gaining importance in the light of the fact that conventional breeding is limited to gene-exchanges between the same or very closely related species whereas transgenic technology enables combining in one plant useful genes from a wide range of living sources and at a relatively shorter time. In fact, in developing countries in particular, biotechnology has the potential to revitalize the agricultural sector, increase the profitability of farming and even, empower the rural sector by boosting food production, enhancing income for the small farmer, and improving his nutritional security. In this context, AgBioAsia 2013 will unveil and discuss the innovative technologies and trends from across the globe.

Modern biotechnology is often misconstrued as the tool for the rich farmers only, but the fact remains that of the 16.7 million people who grew transgenic crops in 2011, 15 million or 90% were small resource-poor farmers in developing countries (Report: ISAAA, Global Status of Commercialized Biotech/GM Crops: 2011). AgBioAsia 2013 will take special interest in dispelling myths like this as well as discuss in detail the benefits and risks of harnessing this new technology, besides the strategies to mitigate the associated risks.

Crop Biotechnology

• •06

According to a study by McKinsey & Company, the Indian food market is poised to grow from US$ 155 billion in 2005 to US$ 310 billion by 2015 and US$ 344 billion in 2025 - at an approximate compounded annual growth rate of 4.1%. India's food processing industry is one of the largest industries in the country - it is ranked fifth in terms of production, consumption, export and expected growth. India is one of the world's major food producers but accounts for only 1.7% (valued at US$ 7.5 billion) of world trade in this sector – this share is slated to increase to 3% (US$ 20 billion) by 2015. The Indian food biotechnology and processing sector is one of the fast growing knowledge-based industries in India and is expected to play a key role in shaping India's rapidly developing economy. Processing contributes to food security by minimizing waste and losses in the food chain and by increasing food availability and marketability, in addition to improving the quality and safety of Food. Biotechnology as applied to food processing is gaining importance with its tremendous potential and scope for producing high value added products with enhanced taste, aroma, shelf-life, texture and nutritional value. Despite the enhanced values, such technologies applied in the processing of food must assure the quality and safety of the final product. AgBioAsia will discuss the prospects and potential of applying biotechnology in food processing operations and to address safety issues in food systems with the objective of addressing food security while responding to changing consumer trends in developing countries.

Food Biotechnology and Processing

• •07

Recognizing the rising importance of the country's Nutraceuticals and natural wealth, AgBioAsia 2013 will conduct a specially designed session to throw light on modern global concepts that complement R&D initiatives in this sector, ways of transforming nutraceuticals from a resource-based to a science-based industry and generating social, economic and environmental benefits. This will also be an opportunity to look at emerging opportunities and challenges arising out of the growing consumer awareness of health and wellness as well as to link the goodness of traditional knowledge with modern practices, technology and emerging business opportunities for the benefit of society. In this context, the forum will involve not just the stakeholders in the section but as well as the academia, government agencies and entrepreneurs who will ultimately drive the growth of the nutraceutical industry.

Nutraceuticals

Participants by sector in AgBioAsia 2013Agri & Food Biotechnology 43%

Food Processing & Technology based enterprises 33%

Environment & Other 34%

Qualitative distribution of participants bysector and type of organization

Agri & Food Food Processing & Environment Other Total Biotechnology Technology based & Industry enterprises

Industry 61 35 5 12 113

Investors 6 5 2 3 16

Professional Services 15 22 11 4 52

Public Organizations 12 10 8 1 31

Technology Transfers & Innovation management 8 5 3 6 22

Research and Education 15 11 1 1 28

Press & Media 4 1 1 4 10

Other (Not yet classified) 3 5 4 3 15

Total 124 94 35 34 287

• •08

AG BioAsia 2013 – Conference Agenda

January 28, 201317:00-18:00 Hrs Inaugural Ceremony

19:00-20:30 Hrs Welcome Reception (Only for Registered Delegates / Speakers & Invitees)

January 29, 201309:30-11:00 Hrs Biotechnology and Social Responsibility - Strengthening the public sector research

11:00-11:30 Hrs Speed Networking (Coffee / Tea Break)

11:30-13:00 Hrs Communicating Biotechnology – approach of scientists and media

13:00-15:00 Hrs Lunch and Visit to the exhibition

15:00-16:30 Hrs Translational Research – Opportunities & Challenges in Public Sector R&D

16:30-17:30 Hrs Food Safety – What all should the regulators consider?

January 30, 201310:00-11:00 Hrs Global Food Security and Climate Change – Addressing through biotechnology

11:00-11:30 Hrs Speed Networking (Coffee / Tea Break)

11:30-13:00 Hrs Stewardship and liability issues in the deployment of transgenic crops

13:00-15:00 Hrs Global Lifesciences Investments – Nurturing Entrepreneurship & Spin offs

15:00-16:30 Hrs Industry-Academia Linkages

16:30-17:00 Hrs Valedictory Ceremony

Programme Itinerary

• •09

BioAsia 2013 was inaugurated by the Chief Guest, , Hon'ble Chief Minister of Shri N. Kiran Kumar Reddy

Andhra Pradesh, on January 28, 2013 at 5:00 pm at Hyderabad International Convention Center, Hyderabad. The Dignitaries present at the function include:

Ms. Carmen Vela Olmo, Hon' ble Minister of State for Research, Development and Innovation,

Ministry of Economy & Competitiveness, Spain

Dr. Maharaj Kishan Bhan, Former Secretary, Department of Biotechnology Govt. of India

Dr. Freda Lewis-Hall, Executive Vice President & Chief Medical Officer (World Wide), Pfizer Inc.

Mr. InKyo Kim, President, Gangwon TechnoPark, South Korea

Dr. George John, Senior Advisor, Department of Biotechnology, New Delhi, India

Dr. K V Raghavan, Vice President, FABA & Chairman, BioAsia 2013 Organizing Committee

Dr. P V Appaji, Director General, Pharmexcil Export Promotion Council, Hyderabad.

Dr. Manni Kantipudi, CEO, GVK Biosciences, Hyderabad, India

CeremoniesInaugural Ceremony:

(L to R)Dr. KV Raghavan, Dr. MK Bhan, Dr. Freda Lewis-Hall, Ms. Carmen Vela Olmo, Shri N. Kiran Kumar Reddy, Mr. InKyo Kim, Dr. George John, Dr. Manni Kantipudi, Dr. P V Appaji

• •10

The Valedictory ceremony was held on 30th January from 16:30 hrs to 17;30 hrs at HICC, Hyderabad

The Chief Guest at the Valedictory Ceremony was Dr. D. Purandeswari, Minister of State for Commerce & Industry, Govt. of India

The dignitaries present at the function include:

Dr. K V Raghavan, Vice President, FABA & Chairman, BioAsia 2013 Organizing Committee

Dr. William D Dar, Director General, ICRISAT, Hyderabad

Mr. Lee Wook Jae, Hon'ble Director General, Global Business Bureau, Gangwon Provincial Government, South Korea

Dr. Khalid J Chowdhry, Chairman & CEO Medipak Ltd., Pakistan & President , FABA

Dr. P V Appaji, Director General, Pharmexcil Export Promotion Council, Hyderabad.

Dr. Sanjay Puri, President, AUSIB, Chairman, USINPAC & CEO, Optimos, Inc.

Mr. K. Pradeep Chandra, IAS Prl. Secy to GoAP and Commissioner for Industrial Promotion, Industries and Commerce Department

Valedictory Ceremony:

(L to R): Dr. KV Raghavan Dr. Sanjay Puri, Dr. Khalid J Chowdhry, Dr. D. Purandeswari, Mr. Lee Wook Jae, Dr. William D Dar, Mr. K. Pradeep Chandra, Dr. P V Appaji

• •11

The organizing committee of BioAsia takes pride in bestowing the Genome Valley Excellence Award 2013 on Dr. MAHARAJ KISHAN BHAN, in light of his –

• Extraordinary Vision and Leadership in changing the Indian Biotechnology Landscape, as the Secretary to Government of India, Department of Biotechnology - The apex body for promoting and regulating biotechnology in the Country

• Commitment to betterment of human health as a physician, clinical scientist and leading advocate in public health, immunization and vaccines.

• Relentless efforts and contributions to the society through various public and private initiatives

Former Secretary, Department of Biotechnology, Govt. of India

Genome Valley Excellence AwardsDr. Maharaj Kishan Bhan

Dr. M K Bhan receiving the award from Hon'ble Shri N. Kiran Kumar Reddy

• •12

The BioAsia Organizing Committee takes pride in bestowing the Genome Valley Excellence Award 2013 to Pfizer Inc, USA in light of

• Its un-waivered commitment to patient health through various Global Health Initiatives, particularly in the emerging markets

• Vision, leadership and focus on cutting-edge Research &Development and it's continued commitment to innovation in the biopharmaceutical space

• Its support and backing to the initiatives clearly focused on preventing and treating orphan disease areas and also related therapeutic areas in Primary care, Specialty care and Oncology.

Dr. Freda Lewis-Hall receiving the award from Hon'ble Shri N. Kiran Kumar Reddy on behalf of Pfizer Inc.

• •13

In order to promote the investigative in young school children and scientist, BioAsia has instituted Innovation and Young mind award in areas of Biotechnology/Lifesciences including Biomedical/ Pharmaceuticals technology, Bioinformatics, Biomechanics to name a few. This year 15 proposals were shortlisted out of 72 received from India and from 6 countries.

BioAsia Innovation & Young Minds Award

BioAsia Innovation Award:BioAsia Innovation Award for 2013 consisting INR 1,00,000 and a memento was presented by Dr. D. Purandeswari, Hon'ble Minister of State for Commerce & Industry, Govt. of India which was shared between Mr. Paritosh Parashar, IIT-Kanpur, Mr. Anshuman Shukla, Punjab University and Mr. Rupam Kumar Bhunia, IIT-Kharagpur.

BioAsia Young Minds Award:BioAsia Innovation Award for 2013 consisting INR 50,000 and a memento was presented by Dr. D. Purandeswari, Hon'ble Minister of State for Commerce & Industry, Govt. of India to Ms. Meghana D Kumar, St. Patricks Junior College, Hyderabad

• •14

Biotechnology and Social Responsibility - Strengthening the public sector researchTuesday, January 29, 2013, 09:30-11:00 Hrs

Conference Details

Our panel of Experts:• Dr. Biksham Gujja, Founder and Chairperson, AgSri Agricultural Services Pvt. Ltd.• Dr. Ajay Parida, MS Swaminathan Research Foundation (MSSRF)• Dr.PS Bhattacharya, Director (Research & Technology), Tierra Seed Science Pvt. Ltd.

Dr. Biksham Gujja was instrumental in establishing AgSri Agricultural Services Pvt. Ltd.

From 2003 onwards, he led a team of professionals in the WWF-ICRISAT Joint Project, which focused on improving water productivity for major crops like rice and sugarcane. As Team Leader, Dr. Gujja developed, refined, and implemented farm-based methods such as the Sustainable Sugarcane Initiative (SSI) and System of Rice Intensification (SRI), which have now received global recognition and attention.

Another critical area of focus for Dr. Gujja has been to establish civil society dialogue forums on specific issues such as water conflicts, the interlinking of rivers, and the Polavaram dam, to facilitate informed decision-making on major water infrastructure projects. He has managed projects in Africa, Asia and Latin America, successfully mobilizing human and financial resources on water management for the WWF network.

From 1993 to 2010, Dr. Gujja worked with WWF, based at Gland, Switzerland, where he started the Freshwater Programme. As Senior Policy Advisor, he contributed to such major international initiatives as the World Commission on Dams, the World Water Commission, the World Water Forum, and others. Dr. Gujja was also involved in establishing projects related to high-altitude wetlands and lakes in Himalayas, river dolphins, thirsty crops initiative, cotton initiative, developing appropriate responses for adaptation and mitigation of climate change, and traditional water management systems.

• •15

Dr.PS Bhattacharya, Director (Research & Technology), Tierra Seed Science Pvt. Ltd.

He has vast experience in Regulatory Aspects of Agri-Biotechnology and Environmental Risk Assessment of Genetically Engineered Crops, Technology Transfer and IPR / PVP–FR. He has been conferred with many awards which includes UNESCO Young Scientist Fellowship (1992), received National Award for Meritorious Invention given by NRDC, (2002) etc. He has authored about 40 research papers in various national and international journals and multiple patents and copyrights.

He started his professional carrier at IIT, Kharagpur as Mission Scientist (1989- 1996). Subsequently he worked with ODC Biotech Industries at Mumbai (1997-1999) as Technical Director. He joined JK Agrigenetics Ltd. Hyderabad, one of the leading Indian Seed company as Head of Biotechnology during 1999 and worked till 2011 as Vice President before starting Tierra Seed Science as Founder Director.

Dr. Partha Bhattacharya did his Master of Science in Botany with specialization on Genetics and Plant Breeding from University of Burdwan, WB and subsequently M.Tech and Ph.D from Indian Institute of Technology, Kharagpur in the area of Biotechnology & Engineering. He has more than “Twenty Years” of research and professional experience in Biotechnology. He is a specialist in Agriculture Biotechnology and Advanced Crop Breeding. He has vast experience in handling several large collaborative technology development projects. He has led the first indigenous Bt Cotton Technology commercialization (Event 1, 2006) in India.

Dr. Ajay Parida, MS Swaminathan Research Foundation (MSSRF)

Ajay Parida, Executive Director, M. S. Swaminathan Research Foundation, has been selected for the prestigious TATA Innovation Fellowship of the Department of Biotechnology, Government of India. The award is to honour and encourage translational scientists dedicated to finding solutions by innovative scientific knowledge and platform technologies.

Selected through a highly competitive process, Dr. Parida has been awarded the fellowship for his research contribution in the area of basic and applied sciences in developing novel genetic combinations for abiotic stress and nutritional enhancement using advanced biotechnological tools.

• •16

Communicating Biotechnology – approach of scientists and mediaTuesday, January 29, 2013, 11:30-13:00 Hrs

Our panel of Experts:• Dr. Ram Koundinya, MD, Advanta and Chairperson, ABLE-AG• Ms. Joanna Kane-Potaka, Director (Strategic Marketing & Communications), ICRISAT• Ms. Suchismita Roy, Communications and Public Affairs, India at Pioneer Hi-Bred International Inc.• Mr. Pallava Bagla, Science Editor, NDTV

Dr. Ram Koundinya, MD, Advanta and Chairperson, ABLE-AG

He has over 26 year's experience in the seed and agriculture industry. He served as Director of Agricultural Products Division of Cynamid India as well as Managing Director of Cynamid Agro Limited. He served as Managing Director of Emergent Genetics India Private Ltd. He served as an Executive Vice President of Emergent Genetics LLC. His experience includes agrochemicals manufacturing and marketing, operations management, strategic planning and business development throughout India. Prior to joining Emergent Genetics, he held various management positions in agrochemical businesses. He served as Managing Director of Cyanamid Agro Ltd. in Mumbai. He served as Director of the Agricultural Products Division of Cyanamid India and was on the management team of the Agrochemical Division of Hoechst India. He has also worked as the lead for the FTO function in Monsanto India Limited. He served as the Chairman of Crop Life India from 1998 to 2002. He serves as a Director of Warrantify Oy. He has been a Director of Advanta India Ltd. of Pacific Seeds (Thai) Ltd. since July 10, 2009. He has been an Independent Director of AXIS Bank Limited since October 12, 2009. He served as a Director of the Association of Seed Industry, Mumbai from 2002 to 2006. He serves as the Chairman of the Indian Crop Protection Association, an association of research based crop protection companies. Mr. Kaundinya was a an Executive Member of the All India Crop Biotechnology Association, New Delhi from 2002 to 2006.

Mr. V. Ram Kaundinya, Kaundy has been the Managing Director of Advanta India Ltd., holding company of Advanta Semillas SAIC since July 10, 2006 and also serves as its Chief Executive Officer. Mr. Kaundinya serves as the Chief Executive Officer of Advanta US, Inc. He serves as the Chief Executive Officer of Emergent Genetics India Private Ltd. (formerly Paras Extra Growth Seeds Ltd.), a subsidiary of Emergent Genetics, Inc. Mr. Kaundinya also serves as an Executive Vice President of Emergent Genetics, Inc. and Stoneville Pedigreed Seed Co. (Advanta International B.v., Advanta Finance B.v., Pacific Seeds Holdings (Thailand) Limited are also subsidiaries of Advanta India Ltd.).

• •17

Ms. Joanna Kane-Potaka, Director (Strategic Marketing & Communications), ICRISAT

She has also worked for the WorldFish Center in MaIaysia and the Philippines as head of information, Communications and Training and for Bioversity International, Italy/as Information Marketing and Management Head. She worked as Marketing Research Coordinator in agribusiness with the Queensland Department of Primary Industries, Australia in 1989-1995, and before this as a research economist with the Australian Bureau of Agricultural Economics, She has also worked as a marketing .manager In manufacturing and fair trade and with her own business as a marketing consultant in the food industry.

Ms. Joanna Kane-Potaka, an Australian national joined as Director (Strategic Marketing & Communications), ICRISAT at Patancheru on 15 October. She has a Bachelor's degree in Economics, Post Graduate Diploma in Management and a Master of Science (Global Marketing) and is a certified practicing marketer tn both Australia and the UK.

Before joining ICRISAT, Joanna worked as Director, Communications and Marketing Information and Knowledge Group, at the International Water Management Institute (IWMI), Colombo, since 2009.

He is an alumnus of the Andhra Pradesh Agricultural University, Hyderabad from where he graduated with a degree in Agriculture. He is also an alumnus of the Indian Institute of Management, Ahmadabad from where he graduated with a masters in business administration with a specialization in Agriculture.

• •18

Skill Set includes:• Understanding of the entire gamut of the media business.

• Creating synergies between Marketing, Strategy and Revenue Expansion teams.

• An effective communicator & team leader with strong analytical, problem solving & organizational abilities. Possess a flexible & detail oriented attitude. Corporate Positioning & Branding -Leading the Marketing Category i.e Buying for all Marketing Expenditure like Press Relations/Media/ Research/ Conferences/ Promotions/ Printing under Strategic procurement Operations in the Source to Pay SBU.

• Setting up the Corporate Communications Department & Community Relations Departments from scratch for a new organisation since its inception in India, thereby spreading it across States & Cities & Rural areas in the country.

• Developing annual marketing strategy and plan for circle for acquisition & revenue enhancement increasing reach & penetration and tools of internal & external communications.

• Ensuring work programmes covering all functions within the coverage area (health, education & livelihood, Children & Old Age as focus groups), with the aim of bringing about systematic change & Improvement in the working villages; building partnerships with NGO's, Government Machinery, Local Administration to carryout sustainable development projects.

• Possessing the ability to be projected as the Spokesperson of the Organisation apart from focusing Senior Management to External & Internal Stakeholders. Strategic Forecasting

• Specialties: Corporate Communications –– Marketing - Media Relations –Advertising & Sales -Media Planning- Brand Communications-Public Relations - Social Responsibility Initiatives- Crisis & Reputation Management- Govt & Public Affairs

Ms. Suchismita Roy, Communications and Public Affairs, India at Pioneer Hi-Bred International Inc.

An innovative professional with18 yrs of experience in corporate communication, Public Relations, Marketing & brand building , Public Affairs, sustaining Community Initiatives with organizations of repute in diverse industry segments like Agriculture ,Telecommunications, Auto Manufacturing, FMCG, IT, & Advertising. Expertise in management of projects pertaining to New Market openings along with social responsibility in multiple organizations. Significantly improving the brand value of the company.

• •19

Mr. Pallava Bagla, Science Editor, NDTV

A few years ago he joined as Science Editor for India's highly respected private television channel NDTV – New Delhi Television. His work showcasing India's maiden mission to the moon Chandrayaan-1 has been applauded, broadcasting both in English and Hindi.

His solo photo exhibition on water issues titled ̀ Drops of Life' has been globally displayed in New Delhi, Mumbai, Pune, Bhopal and Washington DC.

He is author of several books, the most recent being `Destination Moon: India's quest for Moon, Mars and Beyond.' published by HarperCollins India Private Ltd in 2008. Another, of his books ̀ Trees of India' a large format pictorial book was published by Timeless Books in 2000.

Bagla is also a still photographer working for Corbis, one of the world's largest photo agency owned by Microsoft chief, Mr. Bill Gates. His pictures have found place in respected magazines like National Geographic, Time, Nature, New Scientist, Scientific American, Newsweek, Elle and The Economist.

Pallava Bagla has been a globally acclaimed award winning Indian science communicator and photojournalist for 25 years, and during this time he has come to be respected for his breaking news stories and for having showcased Indian science and technology to the world in more than a decade of writing for Science, the prestigious weekly magazine of the American Association for the Advancement of Science (AAAS), Washington D. C. His work has often led to the government changing its policy.

• •20

Translational Research – Opportunities & Challenges in Public Sector R&DTuesday, January 29, 2013, 15:00-16:30 Hrs

Our Panel of Experts:• Dr. KK Sharma, Principal Scientist (Genetic Transformation), ICRISAT• Dr. Vijayaraghavan, Sathguru Management Consultants• Dr. Derek Russell, CIMBAA Public sector Coordinator, Australia• Dr. Sten Roger Kalla, Founder & Managing Director, Korn Technologies Ltd.

Dr. KK Sharma, Principal Scientist (Genetic Transformation), ICRISAT

His Major Contributions :

1. Involved in conceptualizing and setting-up of an Agri-Business Incubator (ABI) at ICRISAT.

2. Involved in the conceptualization of a Platform for the Translational Research on Transgenic Crops which is currently being set-up at ICRISAT.

He has completed PhD in Botany from the University of Delhi & a Post Doctorate in Biotechnology. He is a member of several governmental, institutional and private sector committees.

He has been closely associated with various programs of ICRISAT since 1992. Prior to this, he worked as a Research Associate, University of Calgary, Canada. Area of Research :1. Experimental Plant Morphogenesis.2. Plant genetic engineering for crop improvement.3. Translation of concepts of genetic engineering into commercial products.4. Business incubation through Public-Private sector partnerships

• •21

Dr. Derek Russell, CIMBAA Public sector Coordinator, Australia

Dr Derek Russell is an Adjunct Professor in the Genetics Department at the University of Melbourne where, for the past eight years he has been the public sector coordinator of a major public/private partnership developing insect-resistant crops for deployment in India and Africa, working with a range of Indian research institutes under funding from the governments of Australia, EU, UK, USA, Taiwan and India.

Dr. Vijayaraghavan, Sathguru Management Consultants

environment. For over 25 years, he has advised several national governments of both advanced and emerging economies to shape their science and technology commercialization policies; technology development and dissemination strategies; enterprise nurturing policies and intellectual assets protection policies.

He is a renowned technology manager with an experience of over 25 years. His multiple majors in graduate programs and fellowship in finance, strategic and technology management, helps nurture enterprises that can effectively complement in-house research capacity with external research capacity to sustain competitiveness. He has helped structure governance and leadership models for global consortiums, corporate enterprises and non-profit organizations. For two decades he has led several collaborative partnerships in research, technology transfer and regional capacity building with Cornell University for the Asian region. He is a visiting faculty at world renowned institutions and believes in sharing his experiences with practicing managers and academics.

He is a member of the International Advisory Committee of AUTM and Honorary President of the Society for Technology Management (STEM), the Indian association of technology management professionals.

K. Vijayaraghavan (Vijay), the chairman of Sathguru Management Consultants, founded the firm in 1985 to integrate proficiencies in science and management to help create and nurture innovative enterprises, by adopting next generation technologies for product development and providing strategic ideas in reaching markets and delivery systems for different segments. He takes special interest in exploring the potential of applying technological innovations in life sciences, to address the problems of resource-constrained communities. His able guidance has helped constitute, some path breaking global consortiums in public health, agriculture, food and

• •22

Dr. Sten Roger Kalla, Founder & Managing Director, Korn Technologies Ltd.

The scientific results from the field trials with GM Forage crops was presented in Kalla et al (2000) Molecular breeding of forage legumes for virus resistance: In Molecular Breeding of Forage Crops: the proceedings of the 2nd International Symposium on Forage Crops. Spangenberg G (Ed.), pp 219 – 237.

Dr SR Kalla was invited to address the XVIth EUCARPIA Plant Breeding Congress in Edinburgh, Scotland in September 2001 to discuss the regulatory framework for work with GM plants in Australia in general and the work on GM forage crops in particular.

Dr SR Kalla was the Executive Officer to the Inter Departmental Canola Review Committee responsible for the Genetically Modified Canola Review commissioned by the Victorian Government in 2003. He held this position as an expert in the field of GM crops trials for the length of the review from October 2003 until March 2004. The outcome of the review was a report containing independent policy advice to the Victorian Government for their decision on the release of two strains of herbicide resistant GM Canola bred for Australian conditions. These two GM canola strains are now grown in Victoria and New South Wales. They are also under assessment in GM field trials in Western Australia and South Australia.

Korn Technologies was founded in 2003 by Dr Sten Roger Kalla. The company owns a share in Intellectual Property that is applicable to the global grains industry. The technology and the IP position are described on the company web site www.korntechnologies.com. So far the technology has been evaluated in Japanese rice (Oryza sativa ssp. japonica) and Maize ( Zea mays L) and proven to work in the seeds of these major staple grain foods.

Dr Sten Roger Kalla has had many years of experience in operating within the framework of The Australian Gene Technology Act 2000, which came into force on 21 June 2001. As a Senior Scientist in a international public private research and development partnership he has been supervising field trials with GM forage crops and providing Annual Reports to the Office of the Federal Gene Technology Regulator (OGTR) within the Australian Government Department of Health and Ageing in Canberra. The OGTR Reports covered the continuing assessment of the Genetically Modified (GM) forage crops at multiple field trial sites in Victoria and New South Wales over multiple growth seasons.

• •23

Food Safety – What all should the regulators consider?Tuesday, January 29, 2013, 16:30-17:30 Hrs

Our panel of Experts:• Dr. B. Dinesh Kumar, Dy. Director, National Institute of Nutrition, Hyderabad• Dr. Eric Boy, Nutritional Coordinator, Global Research Programme, HarvestPlus, USA• Dr. Alok Kumar Srivastava, Head, Food Safety and Quality Control, Central Food Technological Research Institute (CFTRI)

B. Dinesh Kumar, Dy. Director, National Institute of Nutrition, Hyderabad

Among the various products screened, α interferon, recombinant hepatitis B vaccine (rHBv), r-DNA

anti rabies vaccine (under Jai Vigyan Programme ), Traditional Ayurvedic Bhasmas, Stem Cells, Food Supplements is well recognized by all National and International agencies. His contribution in area of Lead Toxicity is detection of early organ toxicities caused due to xenobiotics and identifying the possible preventive agents to reverse the toxicities. He has two International (i. Role of Nutrients in Environmental Toxicity of International Atomic Energy Agency (IAEA), Vienna, Austria, ii. INDO-US collaborative programme of MCHR ) in addition to several national projects on this aspect. One of the major achievement in Social Drug Epidemiology is developing an intervention programme for promotion of rational drug therapy through a film “Haridas – Tale of Medicines (Local Traditional Format to Promote Rational Drug Use) developed by him which became very popular in media. Apart from several publications in peer-reviewed journals. He is a Norman Borlaug Fellow and recipient of Young Scientist Award from AP Academy of Sciences (1993), Indian Pharmacological Society –1991 (IPS). Nutrition Society of India -1986 (NSI), Associate Member –AP Academy of sciences (2003). Served as National General Secretary (2007-11) Indian Pharmacological Society. He is Expert member / Member (ICMR) for Expert Committee for promotion to conduct clinical trials on Ayurveda, Siddha, Unani (ASU) Drugs,Ministry of Health & Family Welfare, Draft rules for financial compensation in the case of trial related injury or death, Constitution of Clinical Trial Monitoring Cell in CDSCO, Advisory Committee National Dope Testing Laboratory (NDTL).

Doctorate in Pharmacology (faculty of medicine), Presently working as Scientist –“E” (Deputy Director), Food and Drug Toxicology Research Centre of National Institute of Nutrition (ICMR). He is group leader working in the area of, i) Pre-clinical Efficacy Safety Evaluation of Therapeutic Agents (Bio-Pharmaceuticals, GMO's, & Innovative therapies, Traditional preparations, Nutraceuticals) ii) Detection of Lead Toxicity. iii) Social Drug Epidemiology. Among the various achievements. As a Pharmacologist, in a team of expert scientist's from Pathology, Biochemistry, Immunology, Microbiology, a challenging work on safety evaluation of indigenously developed products has been undertaken for the first time in the country.

• •24

Dr. Boy obtained his medical degree from the University of San Carlos in Guatemala (1987) and his M.Sc. and Ph.D. in Nutrition at the University of California at Davis. Before joining HarvestPlus, he was Regional Coordinator for micronutrient nutrition technical cooperation for the Institute of Nutrition of Central America and Panama (INCAP/PAHO). He also spent nine years at the Micronutrient Initiative (MI) where he managed Latin American projects and the vitamin A supplements procurement project.Expertise: Micronutrient malnutrition, complementary foods, children under five years of age

Dr. Eric Boy, Nutritional Coordinator, Global Research Programme, HarvestPlus, USA

Dr. Alok Kumar Srivastava, Head, Food Safety and Quality Control, Central Food Technological Research Institute (CFTRI)

• •25

Global Food Security and Climate Change – Addressing through biotechnologyWednesday, January 30, 2013 10:00-11:00 Hrs

Our panel of Experts:• Dr. Suresh Pande, Principal Scientist, Legumes Pathology, ICRISAT• Prof. Sagadevan G. Mundree, Deputy Director, Centre for Tropical Crops and Biocommodities, Queensland University of Technology, Australia

Dr. Suresh Pande, Principal Scientist, Legumes Pathology, ICRISAT

In participation with farmers and national programs, he has developed and advanced components of IDM for cereal diseases (sorghum downy mildew and charcoal rot, downy mildew of millet, rusts and smuts of wheat and blast disease of finger millet) in Africa (Kenya, Mali, Nigeria, Niger, Zimbabwe, Zambia) and legumes diseases (leaf spots of groundnut, botrytis gray mold of chickpea and wilts of chickpea and pigeonpea), in Asia (Afghanistan, Bangladesh, China, Nepal, Pakistan, India).

Dr. Pande is a PhD, Plant Pathology from Indian Agricultural Research Institute and Gold Medalist in MSc. from Himachal Pradesh Agricultural University. He is the author of more than 300 scientific papers, book chapters and information bulletins. He is a Fellow of the Indian Phytopatological Society, Plant Protection Association of India and Indian Society of Pulse Research and Development.

He has received several national and international awards for his outstanding contribution to R4D in the field of IDM, including ISPRD Recognition Award India, the King Baudouin Award of the Consultative Group on International Agricultural Research for Sorghum, Chickpea and Rice-Wheat Consortium, Doreen Margaret Mashler for IPM in Groundnut, Nepal Agricultural Research Council “Letter of honor and Outstanding Scientific Achievement Award, Grain Legumes, in Nepal, Bangladesh Agricultural Research Council – ICRISAT Silver jubilee Distinguished Scientific Achievement Award for Legumes Pathology.

Dr Suresh Pande is a Principal Scientist, with the International Crops Research Institute for the Semi-Arid Tropics for 30 years. He has been leading Legumes Pathology for 20 years. His research, focuses on the host x pathogen x environment interaction to develop and expand user friendly Integrated Disease Management (IDM) for the sustainability of the production of cereals and legumes at subsistence farm level. Recently his team has been awarded a competitive grant to initiate a “Center of Excellence for Climate Change Research for Plant Protection" by Department of Science and Technology Government of India.

• •26

During his PhD studies, Sagadevan received a number of accolades for academic excellence. Sagadevan returned to S.A. in 1997 and took up a Post–Doctoral position in the Botany Department at the University of Cape Town (UCT). In 1998, he was offered a lectureship in the above department. In 1999, he moved to the Microbiology Department where he developed his research further. His research focused on the molecular dissection of abiotic stress tolerance in plants using the monocotyledonous resurrection plant Xerophyta viscosa as a model system. He received the Distinguished Teacher Award at UCT in 2004, and is a member of the South African Academy of Science. Sagadevan has been inspired by the role of entrepreneurship and innovation in the biological sciences. He was appointed Chief Executive Officer of PlantBio, the National Innovation Centre for Plant Biotechnology in 2004 where, together with the support of a highly dedicated Team he played a significant role in developing the Plant Biotechnology Sector in South Africa. Prof. Sagadevan was recruited by the Department of Primary Industries and Fisheries in February 2007 and led a Team that was responsible for the Queensland Primary Industries and Fisheries´ Investments in Research, Development and Extension in all the primary industries of Queensland. Sagadevan is currently Professor and Deputy Director of the Centre for Tropical Crops and Biocommodities at Queensland University of Technology.

Sagadevan G. Mundree was born in Durban South Africa on the 1st November 1965. He graduated from the University of Durban–Westville (UDW) in 1988 with a B Paed(Sci) degree. He spent four years teaching biology at Arena Park Secondary in Chatsworth. During this period, he completed his BSc(Hons) degree in the Botany Department at UDW. In 1992, Sagadevan was awarded the Fulbright Scholarship to pursue his PhD studies in the Department of Botany and Microbiology at Auburn University (USA). During the subsequent four years, he investigated the molecular determinants of salinity stress tolerance using Nicotiana tabacum as a model plant.

Prof. Sagadevan G. Mundree, Deputy Director, Centre for Tropical Crops and Biocommodities, Queensland University of Technology, Australia

• •27

Stewardship and liability issues in the deployment of transgenic cropsWednesday, January 30, 2013 11:30-13:00 Hrs

Our panel of Experts:• Dr. Paresh Varma, Director (Research), BioSeeds• Mr. Rajvir Rathi, General Manager, Market Acceptance, South & East Asia, Bayer BioScience, India

Dr. Paresh Varma, Director (Research), BioSeeds

Dr. Verma is currently serving on the Governing council of National Seed Association of India.

Before joining the seed industry Dr. Verma has worked in University of Nebraska,International Sorghum and Millet Consortium (INTSORMIL) and ICRISAT.

Mr. Rajvir Rathi, General Manager, Market Acceptance, South & East Asia, Bayer BioScience, India

Dr. Verma holds a Ph. D. in Agronomy with specialization in Breeding from University of Nebraska and M.Sc.Ag Plant Breeding from GB Pant University of Agriculture and Technology, PantNagar

Dr. Paresh Verma has been working in the seed industry since 1992. He is currently working as Director of Research in Bioseed Research India Pvt Ltd. and is responsible for Bioseed's Research and Product Development efforts world wide. Prior to joining Bioseed, he was Head of Research in Proagro Seed Co Ltd (now Bayer BioScience Ltd) and was responsible for research and product development in India.

• •28

Global Lifesciences Investments – Nurturing Entrepreneurship & Spin offsWednesday, January 30, 2013 13:00-15:00 Hrs

Our panel of Experts:• Dr. Prem Pavoor, Director, FIL Capital Advisors (India) Private Ltd• Mr. Anand Govindaluri, Managing Director, Govin Holdings, Singapore• Dr. Makarand Jawadekar, Former Director, Pfizer Research and Development, USA• Moderator – Mr. Vishal Gandhi, Founder & CEO, BioRx Venture Advisors Pvt. Ltd.

Dr. Prem Pavoor, Director, FIL Capital Advisors (India) Pvt. Ltd.

Prior to McKinsey, Prem served as an engineering consultant to the Mitsubishi Chemical Corporation (Japan) and to Alkermes, Inc. (US) on design and scale-up of manufacturing processes.

Prem's doctoral thesis work, performed at the Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital (Boston), focused on enhancing the performance of medical implants. The work is the subject of several international peer-reviewed publications and a U.S. patent. Prem was awarded the 2004 MIT-OMNOVA award for Excellence in Polymer Research for his thesis contribution.

Prem holds a Bachelors degree in Chemical Engineering from the Institute of Chemical Technology (formerly UDCT), Mumbai, a MS and Ph.D. in Chemical Engineering Practice from the Massachusetts Institute of Technology (MIT) and an MBA from MIT Sloan.

Prem is a Director at FIL Capital Advisors (India) Private Limited, where he focuses on sectors that include life sciences, speciality chemicals, agriculture, infrastructure (waste and water management), and energy. Prem brings a cumulative 10 years of experience in management consulting, engineering consulting and technology research, both in the United States and in India. Most recently, Prem was an Engagement Manager with McKinsey & Company (New Jersey and India) where he advised pharmaceutical/biotech, consumer goods and private equity clients on areas that included R&D, business development, post-merger integrations and manufacturing.

• •29

Anand serves as Chairman of the Board of Mobi2Fun Mobile Entertainment, a leading mobile gaming company in India; Industry Advisoy Board for Linkstar Microtronics, Singapore and Innovation Advisory Grant member of Singapore-MIT Alliance for Research & Technology in Singapore. He is also a Start-Up mentor appointed by Action Community of Entrepreneurship (ACE), Singapore and served as a Judge for Start-Up Chile, Start-Up Singapore and Lee Kuan Yew Business Plan Competition organised by SMU, Singapore.

Prior to starting GO-VIN, Anand served as Senior Vice President & Head of Investments and Spin-Off Management at Exploit Technologies, a member of Singapore Government's A*STAR (Agency for Science, Technology & Research) for 3 years, wherein he managed a portfolio of 40 hi-tech companies. Prior to joining A*STAR, Anand was at Temasek Holdings, Singapore where he has executed investments in more than 25 companies worldwide over 8 years. Some of his key investments include: Quintiles (USA), BioVex Inc (USA)-acquired by Amgen for $1billion, Mylan Labs (India/USA), Dr Reddy Labs (India), Medreich Limited (India), Idun Pharma(USA)-acquired by Pfizer, Agilix Inc (USA)-acquired by Perkin, Renovo (Manchester), Arpida (Basel), Intercell (Austria), Biosensors International (Singapore), Merlion Pharma (Singapore), etc.

Anand has a Masters' in Business Administration from the California State University East Bay, USA; Masters' in Biological Sciences from the National University of Singapore and Masters' in Molecular Biology and Biotechnology from G B Pant University, India.

Anand Govindaluri is the Founding Director of GO-VIN Holdings which is an Asia-centric investment advisory company headquartered in Singapore. GO-VIN Holdings is focused on investment advisory, seed investments and corporate social responsibility.Anand Govindaluri is an investor by profession with 14 years of experience in investing in biomedical sciences and ICT companies globally. He focuses across the value-chain of investments - from deal sourcing, to conducting on-site due-diligence, serving on the boards of companies for strategic development and planning exit strategies.

Mr. Anand Govindaluri, Managing Director, Govin Holdings, Singapore

• •30

He has continuous twenty-eight plus years of experience with Pfizer Inc. (Includes R & D and Worldwide Pharmaceutical organization). R & D areas include heading Solids R&D, Drug Product formulation/ Dosage Form/ Drug Delivery research & development, Clinical Trials Supply Manufacturing and Packaging, Scale-up and Technology Transfer as well as Pharmacy (CMC) areas. He managed several functions/groups within Pharmaceutical R&D for many years. In the recent past, he had been also been engaged in creating new alliances, JVs, partnerships and M& A of companies with Pharmaceutical manufacturing, R & D activities with external partners/service providers. He was presented with the "M.L. Khorana Memorial Lecture of the Year Award" at the Indian Pharmaceutical Congress held in New Delhi, India, in December 2001 for his Presentation on 'Advances in Drug Development and Delivery Systems with a Focus on Protection of Intellectual Property Rights'. He has presented at many professional meetings and has participated in various Panel Discussions/Round Tables. He was one of the invited guests for a 'Leadership Summit' held by the President of India, Dr. Abdul Kalam during 2003. He was also one of the invitees to join President George W. Bush's trade delegation to India in March 2006. During December 2007, Mak accompanied Dr. John LaMattina (former Pfizer President) to India on his official trip to India, where President of India, Mrs. PratibhaPatil invited both of them to the President's Palace (RashtrapatiBhavan) in New Delhi. He also recently accompanied Pfizer R & D President Dr. Martin Mackay during Feb 2009 to India for participating in Bio Asia 2009.He served as a Vice president of Asia CRG at Pfizer Inc. He recently (Feb 2011) received an honorary Doctorate from DYP Mumbai University.

He also serves on the prestigious global "Judging Panel"/ Executive Review Board instituted by IBC/ InformaPharma Group for their Annual Pharmaceutical Annual Achievement Awards, as well as European Outsourcing Awards by Via-Media Ltd.

He currently serves as a member on the Editorial boards for 'Bio/Pharmaceutical Outsourcing Report' as well as for "Contract Pharma" a monthly publication. He also is on the Editorial Advisory Board for monthly publication namely, "Pharmaceutical Technology Europe".

Dr. MakJawadekar was formerly a Director, Portfolio Management & Analytics, Pfizer, Inc. at Groton-New London, CT. In the recent past, he was responsible for Benchmarking R & D Portfolio for Pfizer, working with Benchmarking Forums (CMR/KMR), Drug Delivery Technology Assessment function involving external 'Drug Delivery' technologies. He has extensive experience in creating and cultivating external partnerships and alliances for drug delivery technologies for Pfizer Global R & D. He began his professional career at Pfizer Central Research in early 1982, after having completed his Ph.D. in Pharmaceutics at the University of Minnesota.

Dr. Makarand Jawadekar, Former Director, Pfizer Research and Development, USA

• •31

Prior to joining YES BANK in September 2006, he has worked with, FICCI, Genomic Solutions - U.K, Ranbaxy Laboratories and Dabur India Limited in various capacities. He has over 12 years of diverse experience in Healthcare Financing, Strategy, business development, and public policy advocacy. In his previous role at FICCI, Vishal was actively involved in taking up policy issues with the various government departments to create a better business environment for the Biotechnology, Healthcare & Pharmaceuticals sectors. He has been a part of various business delegations to USA, China and U.K for facilitating Biotechnology and Pharma Bilateral trade.

Vishal is a member of various sectoral taskforces of the respective industry associations, including CII, FICCI, ABLE, OPPI, IDMA, and Department of Biotechnology, USIBC taskforce for Biotechnology and Nanotechnology, among others. He has been often quoted on all the leading business news-paper for his views related to major deals in the sectors. He was also a Jury member for Bio-spectrum awards for the year 2011.He holds an executive management degree from XLRI, Jamshedpur with specialization in finance and strategy. He completed his Master's degree in Biotechnology from Central University, Hyderabad and a Bachelor's degree in Life Sciences honours from Delhi University respectively. In addition to this, he has obtained a PG diploma in IPR management from Institute of intellectual property development under the aegis of WTO.

Vishal Gandhi is Founder, Managing Partner and CEO at BIORx Venture Advisors. At BIORx ,he leads the execution of various Strategic Advisory / Technology Transfer / Project Appraisal/Corporate Finance/ Investment Banking( M&A) deals in Life Sciences and Healthcare sectors from seed stage to growth and mature stage companies. At YES Bank where he worked for 6 years, he had significantly developed the Life Sciences and Healthcare Vertical and dealt with more than 300 related organizations and closed more than 35 transactions in the area of M&A/Private Equity space/Debt.

Moderator – Mr. Vishal Gandhi, Founder & CEO, BioRx Venture Advisors Pvt. Ltd.

• •32

Industry-Academia LinkagesWednesday, January 30, 2013 15:00-16:30 Hrs

Our panel of Experts:• Dr. W. Selvamurthy, Distinguished Scientist & Chief Controller R&D, Defense Research & Development Organization (DRDO)• Prof. Jordan Cohen, Vice President for Research and Economic Development, University of Iowa, USA• Prof. Lam Kong Peng, Director, Bio-Processing Technology Institute, A-Star, Singapore• Dr. Taslimarif Saiyed, Director and COO, Centre for Cellular and Molecular Platforms, NCBS-TIFR, Bangalore• Moderator - Mr. Vinod Kuberkar, MD, VTK Lifesciences Advisory Services

Dr. W. Selvamurthy, Distinguished Scientist & Chief Controller R&D, Defense Research & Development Organization (DRDO)

Dr W Selvamurthy joined DRDO in 1973 and during the 36 years of service in DRDO he has had a meritorious career and became Director of two DRDO institutes i.e. Defence Institute of Physiology and Allied Sciences (DIPAS) & Defence Institute of Psychological Research (DIPR) in the year 1992 and held this position for 10 years. He has personally made significant research contributions for the benefit of the soldiers in the fields related to:

• Physiological acclimatisation at high altitude

• Application of yoga for the armed forces

• Discovered a drug to save war casualties subjected to severe hemorrhage

• Psychological stress and its management

• Life support systems for soldiers in extreme operational environments

Dr W Selvamurthy, Distinguished Scientist has been appointed as Chief Controller R&D for Life Sciences (LS) and International Cooperation (IC) since May 3, 2011. He is post-graduate in Human Physiology from Christian Medical College, Vellore (1972) and Ph.D from University of Delhi (1982) and Doctorate of Science (D.Sc.) from Swami Vivekananda Yoga Anusandhana Samsthana (Deemed University), Bangalore (2006). He has been awarded the Degree of Doctorate of Science (D.Sc.) (Honoris Causa) in recognition of his eminent attainment in the field of science and his distinctive place in the scientific world by Fakir Mohan University, Balasore (2008). Recently he has also been awarded Doctorate of Science (D.Sc.) (Honoris Causa) from Bharathiar University, Coimbatore (2009).

• •33

Currently, he has interests in leadership issues in the health professions and the effects of the changes in health care delivery on health professions education and research.

Dr. Cohen is a Fellow of the American Association of Pharmaceutical Sciences and the American Pharmaceutical Association's Academy of Pharmaceutical Research. He was elected to the United States Pharmacopeia (USP) Board of Trustees In 1990, and served as Chair from 1995-2000 and currently serves as the USP member of the AMA's adopted drug names council.

He has been active in state and regional economic development activities in both Kentucky and Iowa and served on the Bioscience Alliance committee of the Iowa Department of Economic Development and the Board of Directors for both Priority One and the Iowa City Area Development Group.

Jordan L. Cohen was appointed Interim Vice President for Research at the University of Iowa in March of 2008, after serving 8 years as Dean of the College of Pharmacy and 11 ½ years in a similar capacity at the University of Kentucky.A native of Milwaukee, Wisconsin, he received his B.S. in pharmacy in 1965 and Ph.D. in pharmaceutics and analytical chemistry in 1969 from the University of Wisconsin-Madison. He served on the faculty at the University of Southern California for almost 18 years where his research focused on clinical pharmacology of anticancer and anti-aids agents and drug disposition in the elderly.

Prof. Jordan Cohen, Vice President for Research and Economic Development, University of Iowa, USA

• •34

Prof. Lam Kong Peng, Director, Bio-Processing Technology Institute, A-Star, Singapore

Dr. Taslimarif Saiyed, Director and COO, Centre for Cellular and Molecular Platforms, NCBS-TIFR, Bangalore

He was seconded to A*STAR Biomedical Research Council where he served as Director (2003), Deputy Executive Director (2004) and Acting Executive Director (2005-2006) while concurrently heading a research laboratory at the Center for Molecular Medicine (CMM). He returned to full-time research in October 2006 and was the founding Executive Director of the Singapore Immunology Network (SIgN), a post he held from 2006 to 2008.

He joined the Bioprocessing Technology Institute (BTI) as Scientific Director in May 1 2008, and is currently its Executive Director. Kong-Peng also holds tenured Full Professorship at the National University of Singapore and Adjunct Full Professorship at the Nayang Technological University and sits on various BMRC and NMRC grant review committees. He was awarded the Arthur Kornberg Memorial Medal by the Asia-Pacific International Molecular Biology Organisation in November 2010.

Kong-Peng Lam obtained his BA (summa cum laude) at the University of Minnesota and his M.A., M.Phil and PhD at Columbia University in the USA. Thereafter he joined the Institute for Genetics at the University of Cologne in Germany as a postdoctoral research scientist, where he was awarded both the EMBO and HFSP long-term fellowships to study B cell development using conditional gene knockout approaches. He returned to Singapore in 1998 and assumed the position of Principal Investigator at the Institute of Molecular and Cell Biology (IMCB). In 2002-3, he attended the Sloan Fellow Program at Stanford University Graduate School of Business where he graduated with an MSc (Mgmt) degree.

Dr. Taslimarif Saiyed is the Director and COO at the Centre for Cellular and Molecular Platforms (C-CAMP), a Dept. of Biotechnology, Govt. of India initiative, in Bangalore, India. Dr. Saiyed's initial training has been in neuroscience where he received his PhD from Max-Planck Institute for Brain Research, Germany and followed up by postdoctoral training at University of California San Francisco (UCSF). At the same time, he also underwent training in management for Biotech and Innovation from QB3 at UCSF, UC Berkeley and UCSC. Earlier, Dr. Saiyed has been selected as “one of the top-20 young scientists” by Roche in 2004.

Individually, he is actively involved and impassioned for promoting innovation in lifescience through supporting translation of discoveries to application, entrepreneurship and technology development.

• •35

Dr.Vinod Kuberkar completed his Integrated M.Tech in biotechnology from the Indian Institute of Technology at Delhi and PhD from the University of Colorado at Boulder, USA. He also has PGPX MBA from the Indian Institute of Management at Ahmedabad. In his professional career, he has worked for Amgen (California), Baxter Healthcare (Maryland), and Sulzer Biologics (Colorado) in the US, and Wockhardt Biotech (Aurangabad) and Intas Biopharmaceuticals (Ahmedabad) in India. His diverse roles have spanned both technical and techno-commercial domains. He left salaried career to pursue entrepreneurship and has started two biotechnology companies. VTK Lifesciences provides specialized services to pharmaceutical and biopharmaceutical companies in technical and techno-commercial areas

Moderator - Mr. Vinod Kuberkar, MD, VTK Lifesciences Advisory Services

• •36

The International Tradeshow was successfully hosted by AgBioAsia 2013. The show comprised of 78 stalls and 15 BioAsia Innovation and Young Minds short-listed candidates.

International Tradeshow

The exhibitors' participation included booths from the Spain, Netherlands, UKTI, EBTC, Iran Bio, Australia, Taiwan, USA, Austria; government bodies such as DBT-BIRAC, IICT, Pharmexcil; state partners from Madhya Pradesh and Karnataka; domestic companies like GVK Biosciences, Bharat Biotech, GE Healthcare, Natco Pharma, Lonza India, Vins Biotech, Springer India, Makrocare Clinical Research Pvt. Ltd., Micro Therapeutics, Scientific Research Instruments, ClinSync Clinical research, Tech Pharma, Noki Technologies, Ramachandra Innovis, RCC Laboratories, ICRISAT, Integrated Clean Rooms, Access Livelihoods Consulting India Pvt. Ltd., Canara Bank and educational institutes. Around 1200 delegates/visitors participated in the tradeshow during the event. Pavilions that showcased the Genome Valley and BioAsia Theme Pavilion were the highlights of the exhibition.

• •37

AgBioAsia 2013 successfully conducted B2B (one to one business meetings) during the event within a dedicated partnering ares. It offered individual meetings space for the private one-to-one meetings and over 350 private meetings were realized during the three days with a listing of over 440 requests from the Biopartnering community.

Business Partnering

The BioAsia partnering community comprised of global thought-leaders, scientific experts, decision makers from the industry, top notch CEOs and regulatory experts from the industry, research organizations and institutional authorities.

AgBioasia also offered a free online partnering system which proactively supported the partnering delegates, exhibitors and sponsors of the event for networking and scheduling meetings during the three days of the event.

• •38

• •39

Gallery

Media Coverage

• •40

MOFPIGovernment of India

ORGANIZERS SPONSOR

BioAsia Secretariat:204, ‘B’ Block, Imperial Apartments, Greenlands Circle, Ameerpet, Hyderabad-500 016, Andhra Pradesh, India

Tel: +91 40 6644 6477 / 6577, Email: info@bioasia.in